Table 1.
Demographic and disease characteristics of donors
| Characteristics | C-SF-MSCs (n = 10) |
E-RA-SF-MSCs (n = 9) |
L-RA-SF-MSCs (n = 12) |
P value* |
|---|---|---|---|---|
| Age (years) | 23.0 (1.22) | 55.4 (14.1) | 58.5 (8.6) | - |
| Women | 3 (30%) | 8 (88.8%) | 12 (100%) | - |
| Positive for rheumatoid factor | - | 8 (88.8%) | 12 (100%) | - |
| Positive for anti-CCP antibody | - | 8 (88.8%) | 12 (100%) | - |
| DAS28-ESR | - | 5.1 (1.4) | 4.6 (1.1) | - |
| Disease duration (years) | - | 1.7 (1.1) | 13.8 (5.1) | 0.011 |
| Modified Sharp score | - | 7.9 (8.8) | 49.7 (26.4) | 0.015 |
Data are means (SE) or n (%), *P value indicates E-SF-MSC vs. L-SF-MSC. C-SF control synovial fluid, ERA or LRA early or long-standing rheumatoid arthritis, MSC mesenchymal stem cell, CCP cyclic citrullinated peptide, DAS28-ESR disease activity score 28-erythrocyte sediment rate